Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

RUSSO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 38.098
EU - Europa 12.961
AS - Asia 5.062
AF - Africa 129
SA - Sud America 80
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 27
Totale 56.391
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.034
IT - Italia 3.625
CN - Cina 2.463
FI - Finlandia 2.294
SG - Singapore 1.827
DE - Germania 1.808
UA - Ucraina 1.350
RU - Federazione Russa 894
GB - Regno Unito 773
IE - Irlanda 739
SE - Svezia 500
FR - Francia 209
BE - Belgio 198
RO - Romania 195
IN - India 161
KR - Corea 147
TR - Turchia 95
CI - Costa d'Avorio 93
IR - Iran 87
NL - Olanda 84
HK - Hong Kong 52
CA - Canada 47
BR - Brasile 46
PL - Polonia 46
ES - Italia 42
JP - Giappone 40
CH - Svizzera 39
AT - Austria 31
GR - Grecia 30
PK - Pakistan 28
AU - Australia 26
EG - Egitto 25
CZ - Repubblica Ceca 23
EU - Europa 23
TW - Taiwan 18
UZ - Uzbekistan 18
LB - Libano 16
BG - Bulgaria 15
MX - Messico 14
IL - Israele 12
CL - Cile 10
MY - Malesia 10
AE - Emirati Arabi Uniti 9
DK - Danimarca 9
VN - Vietnam 9
ID - Indonesia 8
NZ - Nuova Zelanda 8
LT - Lituania 7
PE - Perù 7
PT - Portogallo 7
SA - Arabia Saudita 7
AR - Argentina 6
BD - Bangladesh 6
HU - Ungheria 6
KZ - Kazakistan 6
NO - Norvegia 6
TH - Thailandia 6
ZA - Sudafrica 6
AL - Albania 5
PH - Filippine 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CY - Cipro 4
EC - Ecuador 4
IQ - Iraq 4
CO - Colombia 3
EE - Estonia 3
HR - Croazia 3
KW - Kuwait 3
LK - Sri Lanka 3
MD - Moldavia 3
MK - Macedonia 3
AM - Armenia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
IM - Isola di Man 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
LY - Libia 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
GE - Georgia 1
JM - Giamaica 1
LV - Lettonia 1
MA - Marocco 1
MC - Monaco 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PY - Paraguay 1
QA - Qatar 1
SI - Slovenia 1
UG - Uganda 1
Totale 56.389
Salva come PNG Salva come JPEG
Città #
Fairfield 6.509
Ashburn 3.614
Woodbridge 3.310
Chandler 2.842
Houston 2.710
Wilmington 2.587
Seattle 2.513
Cambridge 2.126
Ann Arbor 1.970
Singapore 1.500
Palermo 807
Medford 775
Dublin 729
Jacksonville 694
Des Moines 567
Altamura 537
Nanjing 533
Princeton 498
Lawrence 418
San Diego 377
Dearborn 332
New York 325
Boardman 273
Santa Clara 271
Ludwigshafen am Rhein 234
Beijing 228
Tulsa 223
Brussels 193
London 172
Shenyang 168
Rome 159
Nanchang 152
Jinan 145
Milan 142
Phoenix 135
Changsha 132
Hebei 127
Helsinki 123
Seongnam 123
Jiaxing 108
Tianjin 108
Bremen 94
Abidjan 93
Falls Church 90
Kitzingen 88
San Paolo di Civitate 88
Kumar 87
Munich 87
Saint Petersburg 86
Izmir 81
Venice 78
Ningbo 77
Zhengzhou 70
Redwood City 68
Los Angeles 67
Guangzhou 64
Tehran 56
Columbus 55
San Mateo 48
Berlin 46
Kilburn 45
Verona 45
Hangzhou 41
Norwalk 41
Chicago 39
Pune 39
Auburn Hills 38
Taizhou 38
Orange 35
Taiyuan 35
Washington 33
Kunming 31
Frankfurt am Main 30
Dallas 26
Haikou 25
Moscow 25
Tappahannock 25
Lanzhou 24
Fuzhou 23
Kraków 22
Toronto 21
Amsterdam 20
Hong Kong 19
Redmond 19
Edinburgh 18
Shanghai 18
Central 17
Hefei 17
Tokyo 17
Atlanta 16
Düsseldorf 16
Hanover 16
Volla 16
Lappeenranta 15
Hounslow 14
Madrid 14
San Francisco 14
Wandsworth 14
Cairo 13
Turin 13
Totale 41.899
Salva come PNG Salva come JPEG
Nome #
S9-Fibronectin, EGF-R, HB-EGF:biomarkers of urothelial damage during intravesical adjuvant therapy? 516
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment 279
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 276
EGFR inhibition in NSCLC: New findings…. and opened questions? 254
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. 222
Cardiotoxic Effects of Anti-VEGFR Tyrosine Kinase Inhibitors 219
Dietary restriction: could it be considered as speed bump on tumor progression road? 212
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 205
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 205
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 203
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 202
Founder mutations in BRCA1 and BRCA2 genes 201
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 201
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 200
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 195
Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. 195
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients 195
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 195
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 194
Relationship between anxiety level and radiological investigation. Comparison among different diagnostic imaging exams in a prospective single-center study 194
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system 194
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 193
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 192
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 191
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 191
Alla ricerca della sicurezza e della qualità: il modello di miglioramento dell’Oncologia nel Policlinico Universitario di Palermo 189
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 189
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 189
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 188
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor 188
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. 188
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 187
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 185
Liquid Biopsy in Breast Cancer 184
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 183
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 181
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 181
Anti-endothelin drugs in solid tumors 180
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 180
Apoptosis: a relevant tool for anticancer therapy. 179
A headlight on liquid biopsies: a challenging tool for breast cancer management 179
The Clinical Significance of Unknown Sequence Variants in BRCA Genes 176
EGFR genomic alterations in cancer: prognostic and predictive values 175
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. 174
HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies:a meta-analysis(1988-2007) 173
THE ROLE OF PSYCHOLOGICAL ASPECTS IN ONCOGENETIC COUNSELLING 173
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 173
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 172
HER2-positive male breast cancer: An update 172
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. 171
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 170
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 170
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 170
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 169
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 169
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer 168
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 167
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 167
Assessment of "grading" with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atypia (FEA) and columnar cell lesions (CCLs) on core breast biopsy. 166
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 166
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 165
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 165
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 165
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 164
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 164
Nintedanib in NSCLC: Evidence to date and place in therapy 164
Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy 163
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 163
The role of Aurora-A inhibitors in cancer therapy. 163
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 163
Targeted Therapies in Hepatocellular Carcinoma 163
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 163
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 162
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis 162
Monoclonal antibodies in gastrointestinal cancers 162
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 161
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 160
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 160
Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. 159
Longevity: Lesson from model organisms 159
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial. 158
Breast cancer genome-wide association studies: there is strength in numbers 158
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 158
Role of curcumin in idiopathic pulmonary arterial hypertension treatment: A new therapeutic possibility 158
Biomarkers and efficacy: Are we nearly there yet? 158
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 158
Role of S128R polymorphism of E-selectin in colon metastasis formation 158
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells 157
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations 157
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients 155
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC) 155
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? 155
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma 155
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 155
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. 154
Emotional expression and coping style in female breast cancer. 154
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 154
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 154
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association? 154
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status 154
Totale 18.084
Salva come PNG Salva come JPEG
Categoria #
all - tutte 232.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 232.256
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.396 0 0 0 0 0 1.878 1.520 1.124 1.378 868 1.226 402
2020/20217.991 505 547 613 803 733 347 749 555 834 841 721 743
2021/20226.735 390 1.383 245 252 293 279 409 359 661 773 617 1.074
2022/20238.881 906 1.700 169 929 936 1.219 496 636 1.326 66 351 147
2023/20243.923 182 523 270 334 279 752 489 325 45 119 55 550
2024/20253.497 219 773 738 884 451 432 0 0 0 0 0 0
Totale 58.974